Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 11OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastric Cancer With Liver Metastases 1

Interventions

fasudil 1exemestane 1dalpiciclib 1citric acid, ispaghula husk, sodium bicarbonate drug combination 1Vi-siblin 1Tamoxifen 1Stents 1Standard of Care 1Psyllium 1Oxaliplatin 1Mammography 1Magnetic Resonance Imaging 1Low-Level Light Therapy 1Lisaftoclax 1Leucovorin 1Laparotomy 1Laparoscopy 1Indocyanine Green 1Immunotherapy 1Fluorouracil 1Endoscopy 1Endoscopic Mucosal Resection 1Drug Therapy 1Control Groups 1Capecitabine 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Immunotherapy × 30 days × Clear all
NCT07602140 2026-05-22

TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study.

Shandong Provincial Hospital

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Gastric Cancer With Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡